Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 68 citing articles:

PROPERMAB: an integrative framework for in silico prediction of antibody developability using machine learning
Li Bian, Senlin Luo, Wenhua Wang, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies
Astrid Musnier, Yannick Corde, A. Verdier, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Optimized Protein–Excipient Interactions in the Martini 3 Force Field
Tobias M. Prass, Kresten Lindorff‐Larsen, Patrick Garidel, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools
Varun Dewaker, Vivek Kumar Morya, Yeon-Ju Kim, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells
Katrin Fischer, Aleksei Lulla, Tsz Y. So, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 4
An Origami Paper-Based Biosensor for Allergen Detection by Chemiluminescence Immunoassay on Magnetic Microbeads
Elisa Lazzarini, Andrea Pace, Ilaria Trozzi, et al.
Biosensors (2022) Vol. 12, Iss. 10, pp. 825-825
Open Access | Times Cited: 17
AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of de novo humanized and sequence-optimized single domain antibodies: a prospective case study
Paul Arras, Han Byul Yoo, Lukas Pekar, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 9
Large-scale data mining of four billion human antibody variable regions reveals convergence between therapeutic and natural antibodies that constrains search space for biologics drug discovery
Paweł Dudzic, Dawid Chomicz, Jarosław Kończak, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows
Tushar Jain, Bianka Prinz, Alexander Marker, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
SUMO: In Silico Sequence Assessment Using Multiple Optimization Parameters
Andreas Evers, Shipra Malhotra, Wolf-Guido Bolick, et al.
Methods in molecular biology (2023), pp. 383-398
Open Access | Times Cited: 8
Stability of Protein Pharmaceuticals: Recent Advances
Mark C. Manning, Ryan E. Holcomb, R. W. Payne, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 7, pp. 1301-1367
Closed Access | Times Cited: 2
A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructs
Itzel Condado Morales, Fabian Dingfelder, Isabel Waibel, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Novel strategies in systemic and local administration of therapeutic monoclonal antibodies
Monika Prašnikar, Maja Bjelošević Žiberna, Mirjam Gosenca Matjaž, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124877-124877
Open Access | Times Cited: 2
Conformational Entropy as a Potential Liability of Computationally Designed Antibodies
Thomas Löhr, Pietro Sormanni, Michele Vendruscolo
Biomolecules (2022) Vol. 12, Iss. 5, pp. 718-718
Open Access | Times Cited: 11
Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies
Carolina Corrêa Giron, Aatto Laaksonen, Fernando Luís Barroso da Silva
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 12, pp. 5707-5727
Open Access | Times Cited: 9
AbNatiV: VQ-VAE-based assessment of antibody and nanobody nativeness for hit selection, humanisation, and engineering
Aubin Ramon, Montader Ali, Misha Atkinson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2
Christof Angermueller, Zelda Mariet, Benjamin W. Jester, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Accurate prediction of antibody deamidations by combining high-throughput automated peptide mapping and protein language model-based deep learning
Ben Niu, Benjamin C. Lee, Lili Wang, et al.
(2024)
Open Access | Times Cited: 1
Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
Monica L. Fernández‐Quintero, Nancy D. Pomarici, Anna-Lena M. Fischer, et al.
Antibodies (2023) Vol. 12, Iss. 4, pp. 67-67
Open Access | Times Cited: 4
Label-free Assessment of Complement-Dependent Cytotoxicity of Therapeutic Antibodies via a Whole-Cell MALDI Mass Spectrometry Bioassay
S. Schmidt, Alexander Geisel, Thomas Enzlein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Enhancing the therapeutic potential of P29 protein-targeted monoclonal antibodies in the management of alveolar echinococcosis through CDC-mediated mechanisms
Cuiying Zhang, Tao Li, Siyu Hou, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012479-e1012479
Open Access | Times Cited: 1
Label-free assessment of complement-dependent cytotoxicity of therapeutic antibodies via a whole-cell MALDI mass spectrometry bioassay
S. Schmidt, Alexander Geisel, Thomas Enzlein, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Monoclonal antibodies: From magic bullet to precision weapon
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Residue-resolved insights into the stabilization of therapeutic proteins by excipients: A case study of two monoclonal antibodies with arginine and glutamate
Tobias M. Prass, Patrick Garidel, Lars V. Schäfer, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
abCAN: a Practical and Novel Attention Network for Predicting Mutant Antibody Affinity
Chen Gong, Yue Shen, Hongde Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Scroll to top